ERYTECH Pharma S.A. Operating Expenses 2011-2026 | ERYP

Annual Operating Expenses ERYTECH Pharma S.A.

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
33.8 M	60.7 M	72.6 M	69.4 M	48.1 M	34.3 M	-	-	-	3.56 M	-	-

All numbers in EUR currency

Indicator range from annual reports

Maximum	Minimum	Average
72.6 M	3.56 M	46 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Autolus Therapeutics plc AUTL	145 M	$ 1.35	-2.91 %	$ 359 M	Britain
Coherus BioSciences CHRS	231 M	$ 1.61	-3.59 %	$ 189 M	USA
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	78.3 M	-	2.54 %	$ 160 B	France
Catalyst Pharmaceuticals CPRX	206 M	$ 24.88	-0.4 %	$ 3.04 B	USA
Corbus Pharmaceuticals Holdings CRBP	85.3 M	$ 10.02	-1.16 %	$ 133 M	USA
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Cardiff Oncology CRDF	49.6 M	$ 1.57	-0.63 %	$ 105 M	USA
Acorda Therapeutics ACOR	206 M	-	-24.86 %	$ 820 K	USA
Alterity Therapeutics Limited ATHE	16.7 M	$ 3.65	1.3 %	$ 8.78 B	Australia
Advaxis ADXS	22 M	-	-9.65 %	$ 45.9 M	USA
DBV Technologies S.A. DBVT	153 M	$ 20.25	-0.54 %	$ 2.83 B	France
Adverum Biotechnologies ADVM	140 M	-	-	$ 86.2 M	USA
Aytu BioScience AYTU	53.7 M	$ 2.55	-4.14 %	$ 16 M	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
Dyadic International DYAI	10.1 M	$ 0.87	-	$ 31.5 M	USA
Aeterna Zentaris AEZS	23 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	24.2 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
Entera Bio Ltd. ENTX	11.3 M	$ 1.17	-2.1 %	$ 64 M	Israel
Equillium EQ	23.6 M	$ 2.0	-0.5 %	$ 115 M	USA
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
Evogene Ltd. EVGN	28 M	$ 0.8	2.49 %	$ 27.9 M	Israel
AIkido Pharma AIKI	179 M	-	1.93 %	$ 17.4 M	USA
Fate Therapeutics FATE	154 M	$ 1.15	-3.78 %	$ 137 M	USA
Forte Biosciences FBRX	70.7 M	$ 26.15	-1.1 %	$ 339 M	USA
Aptose Biosciences APTO	24.7 M	-	-45.71 %	$ 1.2 M	Canada
Fennec Pharmaceuticals FENC	50.9 M	$ 6.2	-3.43 %	$ 177 M	USA
Foghorn Therapeutics FHTX	117 M	$ 4.75	-2.59 %	$ 299 M	USA
Amicus Therapeutics FOLD	528 M	$ 14.46	0.03 %	$ 4.46 B	USA
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
BioNTech SE BNTX	512 M	$ 88.37	-3.19 %	$ 27.2 B	Germany
Akari Therapeutics, Plc AKTX	17.3 M	$ 3.52	-0.56 %	$ 237 B	Britain
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
Fulcrum Therapeutics FULC	84.8 M	$ 7.45	-4.85 %	$ 472 K	USA
Galectin Therapeutics GALT	20.1 M	$ 2.38	-7.03 %	$ 152 M	USA
Allakos ALLK	196 M	-	-	$ 28.6 M	USA
Allena Pharmaceuticals ALNA	47.6 M	-	3.16 %	$ 1.9 M	USA
Alnylam Pharmaceuticals ALNY	1.13 B	$ 315.4	-4.52 %	$ 41.3 B	USA
Alpine Immune Sciences ALPN	88.2 M	-	-	$ 2.17 B	USA
Gilead Sciences GILD	13.5 B	$ 138.37	-1.26 %	$ 172 B	USA
Galmed Pharmaceuticals Ltd. GLMD	32.9 M	$ 0.54	4.26 %	$ 503 K	Israel
Aileron Therapeutics ALRN	50.6 M	-	10.36 %	$ 9.8 M	USA
Genmab A/S GMAB	67.9 M	$ 27.13	-2.25 %	$ 17 B	Danmark
AlloVir ALVR	46.2 M	-	4.14 %	$ 49.1 M	USA